In vivo effects of recombinant IL-2. I. Isolation of circulating Leu-19+ lymphokine-activated killer effector cells from cancer patients receiving recombinant IL-2.

Source:http://linkedlifedata.com/resource/pubmed/id/3257776

J. Immunol. 1988 Feb 15 140 4 1335-40

Download in:

View as

Triples

General Info

PMID
3257776